Related Experiment Video
Updated: May 18, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Current issues in atopic comorbidities and preventing the atopic march
Eric L Simpson1, Lawrence F Eichenfield, Charles N Ellis
1Department of Dermatology, Oregon Health and Science University, Portland, OR 97239-4501, USA. simpsone@ohsu.edu
Seminars in Cutaneous Medicine and Surgery
|October 2, 2012
Summary
Atopic dermatitis (AD) significantly impacts health and quality of life. New research suggests the skin barrier may initiate AD and offers a potential target for prevention strategies.
Area of Science:
- Dermatology
- Immunology
- Public Health
Background:
- Atopic dermatitis (AD) imposes a substantial burden on individuals, families, and public health.
- High prevalence and associated comorbidities like infections and mental health disorders exacerbate the disease's negative impact.
- Quality of life is significantly affected by AD signs and symptoms.
Purpose of the Study:
- To investigate the role of the skin barrier in the initiation of atopic dermatitis.
- To explore the skin barrier as a potential site for allergic sensitization.
- To identify novel targets for atopic dermatitis prevention strategies.
Main Methods:
- This study reviews current research on the skin barrier's function in atopic dermatitis.
- Investigates the mechanisms of skin barrier dysfunction in AD pathogenesis.
- Analyzes the potential for targeting the skin barrier in prevention.
Main Results:
- The skin barrier is identified as a key initiator of atopic dermatitis.
- The skin barrier may serve as a site for allergic sensitization to protein antigens.
- Evidence suggests the skin barrier is crucial in AD development.
Conclusions:
- The skin barrier plays a critical role in the initiation of atopic dermatitis.
- Targeting the skin barrier presents a promising avenue for novel prevention strategies.
- Understanding skin barrier function is essential for managing and preventing AD.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...